PAD treatment hopes dashed
15 November 2007
Hopes that using antibiotic treatment could ease plaque build-up in atherosclerosis or peripheral arterial disease (PAD) have been quashed by US research.
Scientists have been trying to develop an antibody against Chlamydia pneumoniae, after research indicated that this bacterium caused an inflammatory response that exacerbated atherosclerosis and PAD.
But data presented at the American Heart Association scientific sessions, was described as 'a compelling argument that C pneumoniae does not play a role in PAD that is modifiable by antibacterial therapy' by lead researcher Dr Michael Jaff, director of vascular medicine at Massachusetts General Hospital in Boston.
For the study, 145 people with PAD were given the anti-chlamydia antibiotic Rifalazil at doses of 25mg weekly for eight weeks. A further 138 patients were given placebo.
Assessment of peak walking time six months later showed Rifalazil was no better than placebo. Previous trials showed similar negative results.
AHA scientific sessions 4-7 November 2007, Orlando, Florida
Comment below and tell us what you think
Additional Information
Latest jobs Jobs web feed
- Full time GP partner - Isle of Man Laxey and Village Walk Health Centres Competitive, Isle of Man
- General Practitioner x 2 for MOD, RAF Leuchars, Fife MMP Competitive hourly rates offered, East Coast of Scotland
- Locum GPs Urgently South East and South West London- Earn up to £70 per hour! Merco £70/hour, South East and South West London
- Locum Consultant Dermatologists required, Nationwide up to £100/hour Merco Up to £100/hour, Nation-wide
- GP LOCUM SOMERSET AND DORSET Your World Recruitment EXCELLENT, DORSET AND SOMERSET
- Salaried GP Five Elms Medical Practice Negotiable, East London
Most read
Most commented
MIMS Drug Search
Possible searches include drugs (by brand, generic ingredient or drug class), diseases and more.
